The London Clinic expands clinical research programme with
launch of new Advanced Therapies Centre
The London Clinic announces today the launch of the
Advanced Therapies Centre, a new facility which aims to provide
innovative treatment choices for patients by supporting clinical
trials and enabling access to novel therapies.
The Advanced Therapies Centre, which is part of a broader
Clinical Research programme at The London Clinic, and one of the
first clinical trials programme in the independent healthcare
sector, will focus on Phase II and III clinical trials and medical
device trials, offering patients access to the latest advances in
treatments.
The Advanced Therapies Centre provides a number of benefits to
both consultants and patients. It is housed in The London Clinic’s
new £90 million cancer centre, which can provide the latest
treatment, cutting edge technology and world leading expertise. The
Named Patient Programme allows equal access for private patients to
unlicensed medication and off-label treatment in a controlled
environment. Patients involved in the clinical trials will have
consistent care with 24 hour emergency cover to all consultants and
a pharmacy that can formulate treatment as required.
Alisair Gifford-Moore, Clinical
Trials Manager with (from left) Marie Moores, Director, Clinical
and regulatory operations at Theradex, Samuel J With, Managing
Director at DWL, Ian U Matheson, Medical Director at DWL and Dr
Agnes Ograbek, Director of Patient Services at Quintiles
Further benefits of the central coordination of the Advanced
Therapies Centre include a rapid study set up time in 42 days
R&D approval time, compared to 56-120 days in NHS Trusts, as
well as rapid patient recruitment with access via consultants’
private practices, accurate estimation of numbers, and access to
patients unlikely to have taken part in previous clinical
trials.
Alistair Gifford-Moore, Clinical Trials Manager at The London
Clinic Advanced Therapies Centre states “Clinical trials are
vitally important to constantly improve the care of those with
cancer, and the new Advanced Therapies Centre is an exciting step
forward for clinical research at The London Clinic. We are now one
of the first private institutions to fully support clinical trials
programme and, whilst utilising the equipment and expertise we
have, we are able to provide patients with access to novel
therapies, the best possible care options, and new hope for the
future.”
Alistair Gifford-Moore, Clinical Trials Manager
The first clinical trials being undertaken at the Advanced
Therapies Centre focus on oncology, haematology and medical
devices, and will include studies of immunotherapy agents in
pancreatic and colorectal melanoma (and other tumour groups).
Further proposed studies include a comparison of the superiority of
stereotactic radiosurgery with CyberKnife for cancers that have
metastasized. New studies also include a world first
prosthesis/resurfacing knee implant medical device study called
BioPoly.
The Advanced Therapies Centre consists of a multidisciplinary
team of specialist pharmacists, research governance and quality
assurance facilitators, a Macmillan Cancer Information Nurse
Specialist and consultant advisors from the NHS, academia and the
pharmaceutical industry. The Centre further cements The London
Clinic’s commitment to clinical investigation and, as part of a
wider clinical research programme, it also supports the charitable
status by contributing to the scientific foundation of future
clinical treatment and management of patients in the UK.
Alistair Gifford-Moore, Clinical Trials Manager with (left)
Hannah Watkins and (right) Sue Ollier from QED Clinical Services
Ltd
- ENDS -
For more press information, please contact Natasha Lee on 020
8786 3860 or email pressoffice@thelondonclinic.co.uk